ASCO-50TH_1

Featured Posts

June 6, 2014

UChicago Leaves Its Imprint on the 50th Annual ASCO Meeting

 

The theme for ASCO’s 50th annual conference, Science and Society, reflects the growing need to assess maximizing benefits to patients while providing value in a rapidly changing health care environment.

ibrutinib

Featured Posts

May 29, 2014

Tiny Mutation Triggers Drug Resistance for Patients with One Type of Leukemia

 

A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to the highly effective drug ibrutinib.

aacr_banner_700

Featured Posts

May 8, 2014

2014 AACR Annual Meeting Highlights

 

The theme for this year’s 105th AACR meeting was “Harnessing Breakthroughs – Targeting Cures.” UCCCC faculty and investigators led a number of exciting session and delivered top-notch papers and posters.

nci-vol-700x314

Featured Posts

April 8, 2014

The Power of Mobilizing the Immune System for Cancer Therapy

 

Heralded as the “Breakthrough of 2013” by the leading scientific journal Science, cancer immunotherapy is finally getting the attention many in the field thought it long deserved.

20130613_Med-Jahnke_fullteamx700

Featured Posts

March 4, 2014

New Treatment Protocol for Rectal Cancer Saves Pregnant Woman and Her Baby

 

A few weeks after she learned she was pregnant with her first child, Michelle Jahnke was diagnosed with stage 3 rectal cancer. A novel approach by her UCM team saved her and her baby.

Recent Posts by UChicago Cancer Experts

DOD, NIH Funding Allows for Innovative Approaches to Prostate Cancer Research

Vander Griend’s lab examines the role of stem cells, Sox2, and the Hox gene family in prostate cancer development and potential treatment.

 

Dimon in the Rough

The optimism for recovery surrounding J.P. Morgan CEO Jamie Dimon’s public diagnosis of throat cancer highlights the advances made in treating head and neck cancers.

 

For Cancer Patients, New Tool Predicts Financial Pain

Cancer care has a new side effect: financial toxicity. Along with the distress of diagnosis and treatment, more patients are suffering anxiety from the anticipated large, unpredictable costs of treatment and loss of ability to work.

 

The Powerful Impact of Cancer Research

Recent national statistics show death rates for cancer are on the decline. Research has played a big part in this positive trend. But federal budget cuts threaten the progress made over the past several decades. Now is not the time to let up.

 

ASCO 2014: Blending Clinical Innovation with Therapeutic Parsimony

Physicians and scientists from the University of Chicago will play major roles at ASCO’s annual meeting. High-profile topics include studies of new immunotherapy protocols and novel targeted therapies. But much of the chatter will be on who’s picking up the tab?

 
» View Post Archives

Categories